The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 26, 2013
Filed:
Dec. 29, 2011
Julia E. Novak, Bainbridge Island, WA (US);
Scott R. Presnell, Tacoma, WA (US);
Cindy A. Sprecher, Hereford, AZ (US);
Donald C. Foster, Lake Forest Park, WA (US);
Richard D. Holly, Seattle, WA (US);
Jane A. Gross, Seattle, WA (US);
Janet V. Johnston, Seattle, WA (US);
Andrew J. Nelson, Shoreline, WA (US);
Stacey R. Dillon, Seattle, WA (US);
Angela K. Hammond, Redmond, WA (US);
Julia E. Novak, Bainbridge Island, WA (US);
Scott R. Presnell, Tacoma, WA (US);
Cindy A. Sprecher, Hereford, AZ (US);
Donald C. Foster, Lake Forest Park, WA (US);
Richard D. Holly, Seattle, WA (US);
Jane A. Gross, Seattle, WA (US);
Janet V. Johnston, Seattle, WA (US);
Andrew J. Nelson, Shoreline, WA (US);
Stacey R. Dillon, Seattle, WA (US);
Angela K. Hammond, Redmond, WA (US);
ZymoGenetics, Inc., Seattle, WA (US);
Abstract
Antibodies that bind to polypeptides and peptides comprising the sequence of zalpha11 Ligand as shown in SEQ ID NO: 2 are described. The antibodies may bind the full length sequence of 162 amino acid residues or a fragment thereof, including a mature polypeptide of 131 amino acid residues and smaller polypeptide and peptide sequences. The antibodies may include antibodies that are polyclonal, monoclonal, murine, humanized or neutralizing. Methods for producing the antibodies are also described.